2011
DOI: 10.1186/1471-2482-11-1
|View full text |Cite
|
Sign up to set email alerts
|

Unexpected outcome from Trousseau syndrome

Abstract: BackgroundUnprovoked superficial thrombophlebitis and subsequent venous thromboembolism are well-described albeit rare presenting features of advanced visceral malignancy that often manifest too late for curative intervention to be beneficial.Case PresentationWe present the first reported case of early gastric carcinoma presenting with these paraneoplastic phenomena in an otherwise healthy farmer. The early presentation allowed for a curative partial gastrectomy, which itself was complicated by the presence of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
1
1

Year Published

2011
2011
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 13 publications
0
6
1
1
Order By: Relevance
“…A controlled, prospective, randomized clinical trial was carried out based on our previously published study protocol [ 14 ], following approval from the Human Research Ethics Committee of the Universidade Nove de Julho(Brazil) under protocol number 220506/2009. This study is registered with the World Health Organization (Universal Trial Number: U1111-1121-8873) and the Brazilian Registry of Clinical Trials (RBR-9k9hhv).…”
Section: Methodsmentioning
confidence: 99%
“…A controlled, prospective, randomized clinical trial was carried out based on our previously published study protocol [ 14 ], following approval from the Human Research Ethics Committee of the Universidade Nove de Julho(Brazil) under protocol number 220506/2009. This study is registered with the World Health Organization (Universal Trial Number: U1111-1121-8873) and the Brazilian Registry of Clinical Trials (RBR-9k9hhv).…”
Section: Methodsmentioning
confidence: 99%
“…10 In addition to their clinical evidence, adhesions are a major cost factor in health care. 17 If adhesions necessitate surgery, they reoccur in 55 to 100% of patients postsurgically, with an average of approximately 85%. 5 The predominant locations of reoccurrence are the former sites of adhesiolysis.…”
Section: Discussionmentioning
confidence: 99%
“…The treatment of adhesion-related complications contributes substantially to health care costs. In the U.S. adhesiolysis-related costs were estimated to be as much as U.S. $2.3 billion in 2005, 17 corresponding to approximately U.S. $600 million translated to Germany. In a smaller Swedish study comprising 102 patients operated for SBO, there were 273 episodes of SBO with 237 readmissions and 47% of episodes resulting in further surgery within a mean follow-up of 14 years.…”
mentioning
confidence: 99%
“…3 Lack of transport and employment obstacles as reasons for LTFU are supported by a number of other studies conducted in South Africa and Mozambique. 3 ,14, 15 …”
Section: Discussionmentioning
confidence: 99%